The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...

What Happened? Shares of biopharmaceutical company Gilead Sciences (NASDAQ:GILD) jumped 3.3% in the afternoon session after ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with the U.S. government designed to reduce drug costs for ...

Managing DirectorNews Is Out The Choose U World AIDS Day panel brought together three longtime advocates living with HIV to talk about care, stigma and what living with HIV over the long-term means to ...

Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy and Descovy. Biktarvy ...

Key PointsResearch on HIV's conical capsid that began over 25 years ago led to the development of lenacapavir, the world's ...

Callen Lorde boosts HIV prevention access by integrating insurance verification and prior authorizations into EHR workflows, improving care coordination.

Gilead Sciences, Inc. announced that Keeley Wettan has been appointed executive vice president and general counsel, Legal & Compliance, effective immediately, the biopharmaceutical company said ...

In a person living with HIV, proviruses—strands of HIV DNA—are typically integrated into the T cell genome and become a ...

Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective ...

Researchers at Johns Hopkins Medicine have reported evidence that standard chemotherapeutic drugs may selectively suppress ...